Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: A case for switching therapy?
Andrea Santamato, Francesco Panza, Vincenzo Solfrizzi, Vincenza Frisardi, Maurizio Ranieri, Piero Fiore
DOI: 10.2340/16501977-0257
Abstract
This article does not have an abstract
Lay Abstract
Comments
Do you want to comment on this paper? The comments will show up here and if appropriate the comments will also separately be forwarded to the authors. You need to login/create an account to comment on articles. Click here to
login/create an account.
